Vivos Therapeutics, Inc. (VVOS)

Vivos Therapeutics Revenue

Vivos Therapeutics had revenue of $5.14M in the quarter ending March 31, 2026, with 70.46% growth. This brings the company's revenue in the last twelve months to $19.57M, up 33.77% year-over-year. In the year 2025, Vivos Therapeutics had annual revenue of $17.44M with 16.05% growth.

• Revenue (ttm): $19.57M
• Revenue Growth: +33.77%
• P/S Ratio: 0.43
• Revenue / Employee: $73,015
• Employees: 268
• Market Cap: 8.37M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	17.44M	2.41M	16.05%
Dec 31, 2024	15.03M	1.23M	8.91%
Dec 31, 2023	13.80M	-2.22M	-13.87%
Dec 31, 2022	16.02M	-861.00K	-5.10%
Dec 31, 2021	16.89M	3.82M	29.23%
Dec 31, 2020	13.07M	1.67M	14.68%
Dec 31, 2019	11.39M	7.60M	200.44%
Dec 31, 2018	3.79M	-	-

Data Source: Fiscal.ai Last updated: May 20, 2026

Revenue data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 25, 2026

Data Sources Report a data error